Resultats de la cerca - Listing, Joachim
- Mostrar 1 - 20 resultats de 30
- Anar a la pàgina següent
-
1
-
2
Good correlation between changes in objective and subjective signs of inflammation in patients with short- but not long duration of axial spondyloarthritis treated with tumor necro... per Weiß, Anja, Song, In-Ho, Haibel, Hildrun, Listing, Joachim, Sieper, Joachim
Publicat 2014Text -
3
Clinical response to discontinuation of anti-TNF therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab per Baraliakos, Xenofon, Listing, Joachim, Brandt, Jan, Rudwaleit, Martin, Sieper, Joachim, Braun, Juergen
Publicat 2005Text -
4
Serum levels of biomarkers of bone and cartilage destruction and new bone formation in different cohorts of patients with axial spondyloarthritis with and without tumor necrosis fa... per Appel, Heiner, Janssen, Louise, Listing, Joachim, Heydrich, René, Rudwaleit, Martin, Sieper, Joachim
Publicat 2008Text -
5
-
6
Relevance of structural damage in the sacroiliac joints for the functional status and spinal mobility in patients with axial spondyloarthritis: results from the German Spondyloarth... per Protopopov, Mikhail, Sieper, Joachim, Haibel, Hildrun, Listing, Joachim, Rudwaleit, Martin, Poddubnyy, Denis
Publicat 2017Text -
7
Study protocol: Comparison of the effect of treatment with Nonsteroidal anti-inflammatory drugs added to anti-tumour necrosis factor a therapy versus anti-tumour necrosis factor a... per Proft, Fabian, Muche, Burkhard, Listing, Joachim, Rios-Rodriguez, Valeria, Sieper, Joachim, Poddubnyy, Denis
Publicat 2017Text -
8
Long-term outcome of patients with active ankylosing spondylitis with etanercept-sustained efficacy and safety after seven years per Baraliakos, Xenofon, Haibel, Hildrun, Fritz, Claudia, Listing, Joachim, Heldmann, Frank, Braun, Juergen, Sieper, Joachim
Publicat 2013Text -
9
Sustainability of Rituximab Therapy in Different Treatment Strategies: Results of a 3-Year Followup of a German Biologics Register per Richter, Adrian, Strangfeld, Anja, Herzer, Peter, Wilden, Elke, Bussmann, Arnold, Listing, Joachim, Zink, Angela
Publicat 2014Text -
10
Diagnostic accuracy of inflammatory back pain for axial spondyloarthritis in rheumatological care per Poddubnyy, Denis, Callhoff, Johanna, Spiller, Inge, Listing, Joachim, Braun, Juergen, Sieper, Joachim, Rudwaleit, Martin
Publicat 2018Text -
11
Mortality in rheumatoid arthritis: the impact of disease activity, treatment with glucocorticoids, TNFα inhibitors and rituximab per Listing, Joachim, Kekow, Jörn, Manger, Bernhard, Burmester, Gerd-Rüdiger, Pattloch, Dagmar, Zink, Angela, Strangfeld, Anja
Publicat 2015Text -
12
Serum levels of leptin and high molecular weight adiponectin are inversely associated with radiographic spinal progression in patients with ankylosing spondylitis: results from the... per Hartl, Agnes, Sieper, Joachim, Syrbe, Uta, Listing, Joachim, Hermann, Kay-Geert, Rudwaleit, Martin, Poddubnyy, Denis
Publicat 2017Text -
13
Distinct Effects of Interleukin-1β Inhibition upon Cytokine Profile in Patients with Adult-Onset Still’s Disease and Active Articular Manifestation Responding to Canakinumab per Ghannam, Khetam, Zernicke, Jan, Kedor, Claudia, Listing, Joachim, Burmester, Gerd-R., Foell, Dirk, Feist, Eugen
Publicat 2021Text -
14
Risk of incident or recurrent malignancies among patients with rheumatoid arthritis exposed to biologic therapy in the German biologics register RABBIT per Strangfeld, Anja, Hierse, Franka, Rau, Rolf, Burmester, Gerd-Ruediger, Krummel-Lorenz, Brigitte, Demary, Winfried, Listing, Joachim, Zink, Angela
Publicat 2010Text -
15
Long-term effectiveness of tocilizumab in patients with rheumatoid arthritis, stratified by number of previous treatment failures with biologic agents: results from the German RABB... per Baganz, Lisa, Richter, Adrian, Kekow, Jörn, Bussmann, Arnold, Krause, Andreas, Stille, Carsten, Listing, Joachim, Zink, Angela, Strangfeld, Anja
Publicat 2017Text -
16
Corrigendum to: Obesity reduces the real-world effectiveness of cytokine-targeted but not cell-targeted disease-modifying agents in rheumatoid arthritis per Schäfer, Martin, Meißner, Yvette, Kekow, Jörn, Berger, Sylvia, Remstedt, Sven, Manger, Bernhard, Listing, Joachim, Strangfeld, Anja, Zink, Angela
Publicat 2020Text -
17
Obesity reduces the real-world effectiveness of cytokine-targeted but not cell-targeted disease-modifying agents in rheumatoid arthritis per Schäfer, Martin, Meißner, Yvette, Kekow, Jörn, Berger, Sylvia, Remstedt, Sven, Manger, Bernhard, Listing, Joachim, Strangfeld, Anja, Zink, Angela
Publicat 2020Text -
18
Health-related quality of life in patients with long-standing rheumatoid arthritis in the era of biologics: data from the German biologics register RABBIT per Gerhold, Kerstin, Richter, Adrian, Schneider, Matthias, Bergerhausen, Hans-Joachim, Demary, Winfried, Liebhaber, Anke, Listing, Joachim, Zink, Angela, Strangfeld, Anja
Publicat 2015Text -
19
Clinical and functional remission: even though biologics are superior to conventional DMARDs overall success rates remain low – results from RABBIT, the German biologics register per Listing, Joachim, Strangfeld, Anja, Rau, Rolf, Kekow, Jörn, Gromnica-Ihle, Erika, Klopsch, Thilo, Demary, Winfried, Burmester, Gerd-Rüdiger, Zink, Angela
Publicat 2006Text -
20
Hydroxychloroquine in patients with inflammatory and erosive osteoarthritis of the hands (OA TREAT): study protocol for a randomized controlled trial per Detert, Jacqueline, Klaus, Pascal, Listing, Joachim, Höhne-Zimmer, Vera, Braun, Tanja, Wassenberg, Siegfried, Rau, Rolf, Buttgereit, Frank, Burmester, Gerd R
Publicat 2014Text